Follow Us On

Facebook  X  Linkedin  YouTube
 
 

Register for ASIPP's webinars: Controlled Substance Management, Strategies for Successful Practice Management, Interventional Techniques in IPM, Regenerative and Longevity Medicine in IPM, or ASIPP's 28th Annual Meeting before December 31 for a 25% discount on your registration fee.


Double up on the savings by registering before the end of the year and deducting your registration as a 2025 business expense!

Upcoming ASIPP Webinars

Register today!

Join Us in New Orleans for ASIPP 2026

Earn CMEs, Expand Networks, and Explore the Future of Pain Management

It is our pleasure to invite you to the American Society of Interventional Pain Physicians’ 2026 Annual Meeting, where we will continue to shape the future of Interventional Pain Management.


This 28th Annual Meeting will take place Thursday, March 19 through Saturday, March 21, 2026, at the Hilton New Orleans Riverside in New Orleans, Louisiana.


The 2026 Annual Meeting will provide the tools, knowledge, and connections you need to thrive in the evolving field of interventional pain management.

JOIN or RENEW your ASIPP Membership for the best registration rates.

Hands-On Cadaver Workshops

 

Don't miss the Hands-On Cadaver Workshops taking place March 20 and 21 alongside the Annual Meeting in New Orleans!


These workshops offer practical, guided training in key interventional procedures. This is an invaluable opportunity to sharpen your skills and gain confidence through real-time, instructor-led practice.


  • PNS

Sponsored by Curonix 
(non-CME)


  • Regenerative Medicine

(8 CMEs)



  • Interventional Techniques

(8 CMEs)

Mark your calendars!

After reading the 2026 Abstracts & Poster Presentation Guidelines, complete the form by clicking on the submission form button below. 


Questions should be directed to Savannah Gold at 

sgold@asipp.org or 270.554.9412, ext 4219. 

A limited number of qualifying residents/fellows will receive a scholarship to attend the ASIPP 28th Annual Meeting, March 19-21, 2026 at the Hilton New Orleans Riverside. Recipients of this scholarship with receive reimbursement of their meeting registration, and up to three nights stay at the host hotel. This includes room block rate and tax.


Deadline to apply is February 15, 2026.


Click here for more information.




ASIPP Helps!


End of Year Savings with Tax Benefits





As we approach the end of the year, we want to ensure you don’t miss out on significant savings and valuable member benefits with the American Society of Interventional Pain Physicians (ASIPP), but more importantly tax deductions for year 2025.

 

Renew, register, or join by December 31 to maximize your savings and tax advantage for 2025.

  • It is also time to register for the annual meeting and cadaver workshops with tax deductions for 2025.
  • Register as an ASIPP Member for a 17% discount on your registration for ASIPP’s 28th Annual Meeting in New Orleans, March 19–21 (Register today: http://www.asippmeeting.com)


Benefits are enormous, apart from tax savings:

  • Discounted registration rates for all ASIPP meetings, webinars, and cadaver workshops in 2026
  • Advocacy efforts in Washington DC that protect and elevate the specialty
  • Cutting-edge clinical resources and practice management guidance
  • A network of leading experts and peers in interventional pain management
  • Access to ASIPP’s Endorsed Programs: OnDoc.AI, Willow Risk Advisors, Curi, Fedora Healthcare Solutions, Henry Schein, PedsPal, DocMatter, PainCast, and ASIPP TV
  • Inclusion of your practice in the ASIPP Doctor Finder Public Listing


We encourage you to act now: renew your dues, register for the annual meeting, and secure your end-of-year tax savings before December 31.

  • Well-established group seeking an interventional pain physician with pain fellowship training
  • Comprehensive interventional pain management program with physicians, nurse practitioners, and two Ambulatory Surgery Centers
  • Established interventional pain management practice with strong clinical and research focus
  • High-volume practice that is ethical and fully legally compliant
  • Research and publication opportunities available
  • Early and generous partnership opportunities in both the practice and ASC

 

The Community:

  • Excellent quality of life in a county of more than 60,000 residents, with a regional drawing area exceeding 200,000
  • High standard of living with abundant recreational and social opportunities
  • Strong public school system and a private parochial elementary school
  • Convenient location: approximately 2.5 hours to Nashville and St. Louis; 3 hours to Memphis, Louisville, and Lexington
  • Daily one-hour flights to major international hubs, including Chicago O’Hare and Houston, TX

 

Please email Cindy Jackson at cindy@thepainmd.com with your current CV to schedule an interview or to learn more about this practice.



Doctors Call Health System’s Bluff on Noncompete Agreements  




When physicians at Aspirus St Luke’s Hospital in Duluth, Minnesota, were given an ultimatum to sign amendments to their contracts after a merger or lose their jobs, they called their employer’s bluff.


Now, the state’s attorney general is investigating the Duluth-area hospital system and its parent company after some of the doctors filed antitrust complaints.


The health system says the amendment does not change the terms of physicians’ noncompete agreements included in their original contracts. But doctors argue they are protected by Minnesota’s ban on noncompete agreements, which lawmakers passed in 2023.


Click here to read the full article.

Our Sponsor

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


Click here to apply.

No additional cost for ASIPP members!

This webinar is designed to help pain medicine fellows and early-career physicians navigate the job search. Speakers will break down the pros and cons of key practice types—solo, academic, private group, and corporate-owned—so you can make informed career decisions. The session concludes with a live Q&A, giving you the opportunity to get clear answers to your most important questions.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.



Rare Temporary Flu Complication Can Leave Some Kids Unable to Walk




A 9-year-old girl in Michigan recently made the news after suddenly finding herself unable to walk during a bout with the flu. Before that, she experienced typical flu symptoms like fever, chills, and fatigue, and had plenty of rest and hydration.


"When the fever broke after a few days, I thought she was turning a corner," the girl's mother told Newsweek. "Then suddenly, she started complaining of intense pain in both legs."


After blood work and urinalysis, emergency department doctors diagnosed the girl with benign acute childhood myositis (BACM), a very rare, temporary complication of influenza and other infectious diseases that can occur predominantly in school-age kids, mostly boys.


Click here to read the full article.

Our Sponsor



Methadone, Buprenorphine May Lower Opioid Overdose Risk




Use of medications for newly-diagnosed opioid use disorder (OUD) increased from 2016 to 2019 but remained low, a new cohort study showed. Additionally, methadone and buprenorphine were potentially protective and linked to risk reductions of 86% and 77% for opioid overdose, respectively.


METHODOLOGY:

  • The cohort analysis included data from more than 1.1 million Medicaid beneficiaries aged 18-64 years (52% women; 56% White, 14% Black, and 8.5% Hispanic individuals) from 44 US states. All were newly diagnosed with OUD between 2016 and 2019.
  • Outcomes included time to receipt of medications for OUD and medically treated nonfatal opioid overdose.
  • OUD medications included buprenorphine, methadone dispensed in opioid treatment programs, and extended-release naltrexone.


Click here to read the full article.


Apply now!



January 24 & February 7, 2026



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates


Anticoagulant Reversal Drug Pulled From U.S. Market

Andexanet alfa (Andexxa) was denied full FDA approval last year



Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners.


"The Biologics License Application for Andexxa has been withdrawn for commercial reasons, effective December 22, 2025," a spokesperson from drugmaker AstraZeneca said in an email to MedPage Today.


To some, it may come as no surprise that andexanet is leaving the market, as the pricey direct oral anticoagulant (DOAC) antidote had been rejected for traditional FDA approval last year.


Click here to read the full article.

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Abdominal Wall Abscess as a Nonvisceral Cause of Chronic Abdominopelvic Pain: A Case Report


Xiaolu Linda Zhang, DO, Ashley Wong, DO, Demetri Koutsospyros, MD, Amaresh Vydyanathan, MBBS, MS, Kathryn Breidenbach, MD, Karina Gritsenko, MD, Omar Viswanath, MD, Jeffrey Hu, BA, Sarang S. Koushik, MD, Ja Hyun Shin, MD, and Naum Shaparin, MD

Stellate Ganglion Block for Headache Pain and Cognitive Impairment Associated With Long COVID Persisting Over 12 Months: A Case Report


Bennett Andrassy, BA, Sheetal Tallada, BA, Marcus Harris, MD, and Taif Mukhdomi, MD

 
 

New Issue Now Available

 

NARRATIVE REVIEWS

Advancements in MRI Conditionality of Spinal Cord Stimulation Systems: A Narrative Review of Recent SCS Systems and Their Associated Risks in MRI Operations


Pravardhan Birthi, MD, Mahesh Pattabiraman, PhD, Harish Kalaivanan, MBBS, Aparajitha Rajkumar, MBBS, Vittal R Nagar, MD, PhD, Anterpreet Dua, Mittal S. Prajapati, MD, Akshay Agarwa, and Surabhi Chandra, PhD

Pulsed Radiofrequency Treatment: Evidence for and Applications in Chronic Pain


Thanawut Jitsinthunun, MD, Caixia Li, MD, Tony Kwun-tung Ng, MBBS, and Nantthasorn Zinboonyahgoon, MD, DABA

Is Fibromyalgia a Nociplastic or a Mixed-pain Condition? International, Multidisciplinary Recommendations for Pain Phenotyping in Fibromyalgia Syndrome


Ismail Saracoglu, PhD, Randy Neblett, PhD, Esra Akin, PhD, Bilge Basakci Calik, MD, C. Paul van Wilgen, PhD, Marc Schiltz, PhD, Josue Fernandez Carnero, MD, Bart Morlion, PhD, Pawel Zalewski, MD, Slawomir Kujawski, PhD, Aleksandra Modlinska, PhD, Rainer Freynhagen, Robert Gerwin, MD, Mariana Arias Avila, MD, Paula Rezende Camargo, MD, and Jo Nijs, PhD




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!